No Differences in Risk of Cirrhosis or Hepatocellular Carcinoma Among Treatment Naïve Chronic Hepatitis B Patients by Baseline Hepatitis B Viral Load: A Propensity Score Weighted Analysis
Yang Z, Cheung R, Jou J, Lim J, Wong R. No Differences in Risk of Cirrhosis or Hepatocellular Carcinoma Among Treatment Naïve Chronic Hepatitis B Patients by Baseline Hepatitis B Viral Load: A Propensity Score Weighted Analysis. Journal Of Clinical And Experimental Hepatology 2025, 15: 102540. PMID: 40248346, PMCID: PMC12002867, DOI: 10.1016/j.jceh.2025.102540.Peer-Reviewed Original ResearchChronic hepatitis BRisk of cirrhosisChronic hepatitis B patientsHepatitis B virusBaseline HBV DNAHBV DNAHepatocellular carcinomaNational cohortHepatitis B virus DNA >Naive chronic hepatitis B patientsBaseline hepatitis B virusHepatitis B viral loadChronic hepatitis B virusRisk of hepatocellular carcinomaHigh HBV DNAPropensity score weighting analysisTreatment naive patientsNon-Asian patientsHepatitis B patientsCohort of U.S. veteransIncidence of cirrhosisScore-weighted analysisLong-term riskCHB patientsB patients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply